Case Report (n=1)
No
Absolute Event Rate: 11439% vs 40000%
Early diagnosis and multidisciplinary treatment with lipid-lowering agents and dietary modifications can significantly reduce triglyceride levels in rare cases of neonatal hypertriglyceridemia.
Rapid triglyceride reduction appears feasible in neonatal hypertriglyceridemia; leaves open need for safety data and controlled trials before adoption.
Neonatal hypertriglyceridemia is a very rare condition. Diagnosis in neonatal period is very difficult and is usually diagnosed when acute pancreatitis sets in. Early diagnosis is important as it can prevent the complications associated with the condition that is acute pancreatitis and pancreatic necrosis. Here we present a case of neonatal hypertriglyceridemia who presented to us with respiratory distress but was diagnosed early due to the presence of highly viscous and milky blood. This holds importance as early treatment can reduce the complications and morbidity associated with familial hypertriglyceridemia.
No takes yet. Share an insight, caveat, or question.
Bhatia et al. (2018) conducted a case report in Neonatal hypertriglyceridemia (n=1). Lipid lowering agents (Gemfibrozil, medium chain triglycerides) vs. Baseline was evaluated on Serum triglyceride levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: